University of Maryland Medical System Celebrates Opening of the Roslyn and Leonard Stoler Center for Advanced Medicine

BusinessManasi Praharaj18 Nov 2026

Baltimore, November 18, 2026:  The University of Maryland Medical System (UMMS) today hosted a dedication to celebrate the opening of the Roslyn and Leonard Stoler Center for Advanced Medicine, the new home of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC). The new facility nearly doubles the cancer center’s footprint, enhancing its ability to expand patient care and research to meet the growing demand for state-of-the-art cancer treatment.

The 14-story building, with a distinctive glass front embellished with aluminum-covered mesh sails, includes four floors that will be completed in the coming years to expand other specialized clinical services. The sleek modern structure has transformed the face of the University of Maryland Medical Center’s (UMMC) Downtown Campus and provides a new main entrance at 22 S. Greene Street. It opened its doors to patients in late September.

The Stoler Center for Advanced Medicine is named for Baltimore philanthropists Roslyn and Leonard Stoler, who committed $25 million to advance cancer care at UMGCCC. Leonard Stoler founded the Len Stoler Automotive Group, which owns more than a dozen franchises in the Baltimore area, New York and Florida.

UMGCCC’s patient volume has grown significantly over the last decade, fueled in large part by the increase in patients with complicated cancers requiring multidisciplinary treatment and often lengthy follow-up care. One of only two National Cancer Institute (NCI)-designated comprehensive cancer centers in Maryland, UMGCCC treats 3,700 new patients annually, with 62,000 outpatient visits and 1,400 inpatient admissions. It offers highly specialized treatments, including immunotherapies, such as CAR T-cell therapy and TIL therapy, and personalized therapies tailored to a patient’s tumor type and genetic make-up.

“This new state-of-the-art center brings together the brightest minds, the most compassionate caregivers, the latest in technology and the physical resources of the building, all combining to ensure that we give patients an opportunity for hope,” said Mohan Suntha, MD, MBA, President and Chief Executive Officer of UMMS and Professor Emeritus in the Department of Radiation Oncology at the University of Maryland School of Medicine (UMSOM).

“The Roslyn and Leonard Stoler Center for Advanced Medicine is the shining example of our commitment to the evolution of cancer care,” Dr. Suntha added. “We are excited not just for the patients who are here today but also for the patients who access healthcare anywhere in our medical system. We want them to know that supporting them in their cancer journey are the people and resources of the Greenebaum Comprehensive Cancer Center.”

Taofeek K. Owonikoko, MD, PhD, UMGCCC’s Executive Director and the Kevin J. Cullen, MD Distinguished Professor of Oncology at UMSOM, said the new location increases the cancer center’s capacity to care for patients by 40%, both for inpatient and outpatient care. “With this expansion, we will be able to provide the most advanced, integrated and compassionate care to cancer patients across Maryland and the region now and into the future.”

Dr. Owonikoko said the building was designed first and foremost for patients. “We know that our patients and their families are facing some of the most challenging moments of their lives, and we have created a welcoming environment where they can receive multidisciplinary care from a team of experts and all the support that they need in one location. We have also created a more efficient, well-organized workplace for our team members, and I look forward to seeing how the new space improves collaboration across specialties.”

Not Just a Building

The cancer center will occupy six floors of the new building, with five floors dedicated to patient care and part of a sixth floor used for offices. The building will eventually house other medical specialties, such as acute rehabilitation, general medicine and behavioral health, on the upper floors over the next three years. When the second phase of construction is complete, 10 floors of the 302,900-square-foot tower will be dedicated to patient care.

Bert W. O’Malley, MD, UMMC’s President and Executive Vice President for the Academic Health Division of UMMS and Professor of Otorhinolaryngology-Head and Neck Surgery at UMSOM, said the new facilities for oncology will foster the growth of clinical research and support precision medicine and immunotherapy which are playing an increasingly important role in cancer care and are already a major focus of clinicians and researchers at UMGCCC.

“As the name implies, the Stoler Center for Advanced Medicine will be a place where cancer patients receive the most innovative, technologically advanced care, whether it be FDA-approved therapies or experimental new treatments available in clinical trials through our partnership with the University of Maryland School of Medicine,” Dr. O’Malley said. “This is not just a building, but a concept – a new front door to academic medicine. We expect the Stoler Center for Advanced Medicine will be the center of cancer discovery, cancer innovation and cancer care for the entire state.”

More than 100 people attended today’s dedication, including elected officials, UMGCCC staff and former patients, including former Governor Larry Hogan, who was successfully treated for aggressive lymphoma in 2015 and remains cancer-free. “I came to appreciate the center’s work in ways that I could not have imagined,” Hogan said. “Thanks to the world-class care I received, I had the opportunity to continue serving the people of this great state.”

Leonard Stoler said that he and his wife Roslyn feel fortunate to have been able to support a facility that will be “a place for hope” for people in need. “All that they come for is hope,” he said.

“We have marvelous doctors at UMMS, and they are working feverishly to develop cures and to develop access for the people who need it the most,” Stoler said, adding. “We do what we can. Actually, we do what we must. I hope that we have brought joy to a lot of people.”

His son, Barry Stoler, President of Len Stoler Automotive Group, said, “Our family is incredibly proud and honored to have helped make this magnificent new building a reality, creating a beautiful new home for the University of Maryland Greenebaum Comprehensive Cancer Center. My parents have been major benefactors of the cancer center for well over two decades.”  

“Having a new building that bears their name, dedicated to not only providing lifesaving patient care but also fostering impactful research, is a testament to their commitment to helping others and making a difference in the community,” said Stoler, chair of UMGCCC’s Board of Advisors who served on the fundraising committee for the Stoler Center.

The lobby of the Stoler Center is named in honor of the Greenebaums, recognizing the family’s 30-year legacy of supporting cancer research and patient care at the Greenebaum Comprehensive Cancer Center. The family’s foundation donated $5.5 million to UMGCCC earlier this year.

Investing in Next Generation of Promising Cancer Treatments

UMGCCC has a long history of innovation and has pioneered advances in cancer treatment, including the development of aromatase inhibitors to treat breast cancer by the late Angela Brodie, PhD; the invention of the GammaPod™, a radiation treatment option for early-stage breast cancer; and the development of promising new drug compounds and immunotherapies, including next-generation CAR T-cell therapies.

““For decades, our physicians and scientists have been at the forefront of developing and delivering breakthrough cancer therapies,” said UMSOM Dean Mark T. Gladwin, MD, who is also the Executive Vice President for Medical Affairs at the University of Maryland, Baltimore and the John Z. and Akiko K. Bowers Distinguished Professor and Dean. “From advancing novel CAR T-cell therapies for aggressive lymphomas to being the first in the region to use innovative cell therapies for melanoma and rare sarcomas, our teams are helping transform cancer care. The Stoler Center will provide a patient-centered place of healing and reaffirms our commitment to provide state-of-the-art cancer care for all Marylanders.”

The cancer center also treats hematological conditions, and in April, doctors treated Maryland’s first adult patient with sickle cell disease with gene therapy, a transformative, potentially curative therapy for the debilitating inherited blood disorder. A regional leader in cellular therapies, UMGCCC performs about 150 bone marrow transplants and 100 CAR T-cell treatments for blood cancers each year.

UMGCCC’s annual research funding totals $186.2 million, and the center offers more than 400 clinical trials, with minority participation above 50 percent, well above the national average. UMGCCC is also the academic hub of the University of Maryland Cancer Network, and patients treated at other UMMS hospitals have access through the network to new treatments through clinical trials.

The cancer center floors in the Stoler Center feature 62 large private rooms, updated technology for evaluation and treatment, modern waiting areas, exercise rooms for patients and respite rooms for staff on the inpatient floors, an infusion center with 48 private and semi-private treatment spaces, and a dedicated cancer pharmacy. There is also a healing garden on the first floor for UMMC patients and staff members.

The patient rooms are located on exterior walls and have large glass windows that provide the maximum amount of natural light. The windows can be shaded according to the preference of patients. The mesh sails on the outside of the building not only provide shade but help to reduce energy costs. The rooms are designed to provide a comfortable environment for patients and their families, with sleeping accommodation for caregivers to stay overnight. The center features colorful artwork, most of the pieces by Maryland artists.

Continued Growth and Building  

Over the next 2 to 2½ years, the cancer center plans to open an urgent care center in the building to provide 24/7 access for cancer patients who could be treated and released without a hospital stay, an outpatient area to accommodate a growing number of outpatient bone marrow transplants and cellular therapies, a dedicated unit for the most innovative clinical trials (Phase I trials) and an expanded apheresis unit and cell-processing laboratory.

As the cancer center vacates space in the medical center, construction crews will begin to renovate the former outpatient clinic on the first floor of the hospital for the University of Maryland Golisano Children’s Hospital to expand pediatric oncology services.

The Stoler Center was built by Clark Construction and designed by HDR, an employee-owned global design firm which has designed many healthcare facilities using an immersive design process, drawing on input from staff members, cancer patients and their families, and members of the community. The groundbreaking was held in May 2022. Click here to watch the time-lapse video.

Ron V. Cummins, Jr., MBA, UMMC’s Senior Vice President and Chief Operating Officer, said, “We would not have been able to reach this major milestone without all the hard work of hundreds of employees and contractors who made this spectacular new building a reality. There is still more work to be done, but I want to take this opportunity to offer my heartfelt thanks to everyone involved in this project.”

“The Stoler Center for Advanced Medicine will increase our ability to deliver high-quality healthcare and support our continued growth, enabling us to better meet the medical needs of all Marylanders,” Cummins continued. “It also provides a safe, efficient work environment for our employees.”

Successful “Building for Life” Campaign

Soon after construction began, four floors were added to the Stoler Center’s original design to accommodate other medical services, including rehabilitation for patients with traumatic brain and spinal cord injuries, better aligning these critical services with care provided by the R Adams Cowley Shock Trauma Center at UMMC. Forty-five percent of Shock Trauma’s patients require post-acute rehabilitation.

UMMS plans to move acute rehabilitation services from the University of Maryland Rehabilitation & Orthopaedic Institute to the new building in 2028 while continuing to provide outpatient services at the Woodlawn rehabilitation hospital.

The Stoler Center for Advanced Medicine represents a total investment of more than $500 million. Funding for the center includes the Stolers’ lead gift, $125 million from the state of Maryland, another $60 million from private donors in a successful “Building for Life” campaign, and the remainder in UMMS capital funds. The campaign was led by Kevin J. Cullen, MD, then the cancer center’s director, and William "Brit" Kirwan, PhD, a UMMC board member and Chancellor Emeritus of the University System of Maryland, who served as the campaign chair. It was the largest philanthropic fundraising campaign in UMMC’s history.